NYSE: WELL ยท Healthcare Facility REITs
Welltower (WELL) fair value and price range
As of 15 Nov 2026, Faircurve's model values Welltower (WELL) at $75.03 a share. The stock last closed at $244.78, which puts the model's fair value 69.3% below the price. The fair value sits more than 60% away from the price. Faircurve gives no verdict on a gap wider than 60%.
Revalued . Price is the close of 16 Nov 2026. Welltower Inc.
The report adds the live price, the chart against the range the options market prices and the next earnings date. No account needed.
This week, in three parts
What happenedThe run of 15 Nov 2026 moved the fair value from $58.91 to $75.03 (+27.4%). The model does not yet explain moves on this valuation method.
What the model makes of itThe price of $244.78 is 69.3% above it. The fair value sits more than 60% away from the price. Faircurve gives no verdict on a gap wider than 60%.
What's nextNext report on 9 Feb 2027. Options prices imply a move of about 7% either way over the next month. The next weekly run is on Saturday 21 Nov 2026.
What price range does the model give WELL?
The calibrated range for WELL over 63 trading days is $225.48 to $266.83. It sits around the last close, and its width comes from the volatility that WELL's own options imply (25% a year), calibrated weekly against realised prices (n = 8,038 past valuations, refreshed 14 Nov 2026). Ranges built this way held the price 60% of the time at this horizon. The fair value is the model's opinion and rides beside the range. It is not the centre of it.
The model's own range is $68.38 to $82.51.
The Global Pulse
Faircurve's note after each US session, in your inbox. No account needed.
When does WELL report earnings, and how has the stock reacted?
Welltower's next earnings report is scheduled for 9 Feb 2027. Companies can move their dates.
Options prices on 16 Nov 2026 imply a move of about 5.8% in either direction through the nearest expiry, about 31 days out. That is the size the market is pricing, not a direction. WELL's 30 day implied volatility works out to about 7.2% over one month.
Around its last 8 reports: what the options market priced, and what followed
Each move runs from the last close before the report to the first close after it, so it covers companies that report before the open and after the close. The median size across WELL's last 8 reports, ignoring direction, was 2.9%.
What the options market has priced for a month's move in WELL
How does WELL compare with similar companies?
The companies in healthcare facility reits closest to Welltower in market value, each on the same model and the same date.
| Company | Last close | Model fair value | Gap | Model verdict |
|---|---|---|---|---|
| VTR Ventas, Inc. | $88.90 | $46.80 | -47.4% | Overvalued |
| OHI Omega Healthcare Investors, Inc. | $47.08 | $51.39 | +9.2% | Undervalued |
| DOC Healthpeak Properties, Inc. | $19.84 | $31.13 | +56.9% | Undervalued |
| AHR American Healthcare REIT, Inc. | $58.07 | $22.90 | -60.6% | Gap wider than 60% |
| CTRE CareTrust REIT, Inc. | $37.39 | $33.28 | -11.0% | Overvalued |
| HR Healthcare Realty Trust Incorporated | $19.32 | $17.48 | -9.5% | Overvalued |
| SBRA Sabra Health Care REIT, Inc. | $20.35 | $20.72 | +1.8% | Fairly valued |
| LTC LTC Properties, Inc. | $42.71 | $56.30 | +31.8% | Undervalued |
All healthcare facility reit stocks ranked by gap to fair value
Welltower at a glance
Welltower Inc. (NYSE:WELL), an S&P 500 company based in Toledo, Ohio, is a leader in reshaping healthcare infrastructure.
- Market value
- $179.3B
- Sector
- Real Estate
- Industry
- Healthcare Facility REITs
- Beta to the US market
- 0.12
- First valued by Faircurve
- 4 Jul 2026
How the fair value is worked out: the model values Welltower three ways and blends them; the range around the fair value comes from 2,000 simulations of the dividend model. The full method is documented here.
What changed in the latest valuation?
On 7 Nov 2026 the model's fair value for WELL was $58.91. As of 15 Nov 2026 it is $75.03, a change of +27.4%. The model does not yet explain moves on this valuation method. The model revalues every stock it covers each week, and again after an earnings report.
Questions about Welltower's valuation
Is Welltower stock undervalued or overvalued?
Faircurve's model puts WELL's fair value at $75.03 a share against a last close of $244.78, as of 15 Nov 2026. The fair value sits more than 60% away from the price. Faircurve gives no verdict on a gap wider than 60%.
What is WELL's fair value?
$75.03 a share as of 15 Nov 2026. The fair value blends three methods: a cash-flow multiple against comparable companies, a dividend model, and the value of the properties. The model's own range is $68.38 to $82.51.
What price range does the model give WELL?
$225.48 to $266.83 over 63 trading days. Ranges built this way held the price 60% of the time across 8,038 past valuations, refreshed 14 Nov 2026.
When does Welltower report earnings next?
The next report is scheduled for 9 Feb 2027. Companies can move their dates.
How much has WELL moved on past earnings reports?
Across its last 8 reports the median two session move was 2.9%, ignoring direction. The largest was +5.4% around the report of 10 Feb 2026.
How confident is the model in this valuation?
The model's evidence grade for WELL is high. For real estate investment trusts (REITs) the grade looks at the dividend record: at least three years of paid dividends with no cut. It is not a probability that the fair value is right, or that the price reaches it.
The model's own ideas on WELL
The model holds no idea open on WELL today. Signed-in readers see the rule each idea runs on, the floor and the exit level the model set and its time limit, and the model's closed ideas on WELL with their outcomes. A free account is enough.